Subacute progression of human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis

References

• Araujo A Q, Afonso C R, Leite A C, Dultra S V. Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). Arq Neuropsiquiatr 1993; 51: 325–328
   Google Scholar
• Araujo A Q, Andrade-Filho A S, Castro-Costa C M, Menna-Barreto M, Almeida S M. HTLV-I-associated myelopathy/tropical spastic paraparesis in Brazil: a nationwide survey. HAM/TSP Brazilian Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 536–541
   PubMedGoogle Scholar
• Araujo A Q, Silva M T. The HTLV-1 neurological complex. Lancet Neurol 2006; 5: 1068–1076
   PubMed Web of Science ®Google Scholar
• Carod-Artal F J, Vazquez-Cabrera C. [Rapidly progressive myelopathy due to human lymphotropic virus (HTLV-1)]. Rev Neurol 2000; 30: 98–99
   Google Scholar
• Spastic paraparesis and HTLV-I in the Republic of Panama, Vol.-, - edn, L C Castillo. Alan R. Liss, New Yok 1989
   Google Scholar
• Cruickshank J K, Rudge P, Dalgleish A G, Newton M, McLean B N, Barnard R O, Kendall B E, Miller D H. Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. Brain 1989; 112: 1057–1090, (Pt 4)
   PubMed Web of Science ®Google Scholar
• de The G, Bomford R. An HTLV-I vaccine: why, how, for whom?. AIDS Res Hum Retroviruses 1993; 9: 381–386
   PubMed Web of Science ®Google Scholar
• Gessain A, Gout O. Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1992; 117: 933–946
   PubMed Web of Science ®Google Scholar
• Gotuzzo E, Cabrera J, Deza L, Verdonck K, Vandamme A M, Cairampoma R, Vizcarra D, Cabada M, Narvarte G, De las Casas C. Clinical characteristics of patients in peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis. Clin Infect Dis 2004; 39: 939–944
   PubMed Web of Science ®Google Scholar
• Gout O, Baulac M, Gessain A, Semah F, Saal F, Peries J, Cabrol C, Foucault-Fretz C, Laplane D, Sigaux F, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990; 322: 383–388
   PubMed Web of Science ®Google Scholar
• Harrington W J, Jr, Sheremata W A, Snodgrass S R, Emerson S, Phillips S, Berger J R. Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/ HAM): treatment with an anabolic steroid danazol. AIDS Res Hum Retroviruses 1991; 7: 1031–1034
   PubMed Web of Science ®Google Scholar
• Iwasaki Y. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 1990; 96: 103–123
   Google Scholar
• Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 2002; 186: S187–S192, (Suppl 2)
   PubMedGoogle Scholar
• Kida H, Nakagawa M, Iwasaki H, Moritoyo T, Kawabata M, Arimura K, Osame M. [A case of rapidly progressive HTLV-I-associated myelopathy (HAM)]. Rinsho Shinkeigaku 1997; 37: 802–805
   Google Scholar
• Kiwaki T, Umehara F, Arimura Y, Izumo S, Arimura K, Itoh K, Osame M. The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy. J Neurol Sci 2003; 206: 17–21
   Google Scholar
• Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. AIDS Res Hum Retroviruses 2000; 16: 1705–1709
   Google Scholar
• Kuroda Y, Fujiyama F, Nagumo F. Analysis of factors of relevance to rapid clinical progression in HTLV-I-associated myelopathy. J Neurol Sci 1991a; 105: 61–66
   Google Scholar
• Kuroda Y, Takashima H, Ikeda A, Endo C, Neshige R, Kakigi R, Shibasaki H. Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin. J Neurol 1991b; 238: 309–314
   Google Scholar
• Kwaan N, Lee T H, Chafets D M, Nass C, Newman B, Smith J, Garratty G, Murphy E L. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis 2006; 194: 1557–1564
   PubMed Web of Science ®Google Scholar
• Leite A C, Silva M T, Alamy A H, Afonso C R, Lima M A, Andrada-Serpa M J, Nascimento O J, Araujo A Q. Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy. J Neurol 2004; 251: 877–881
   Google Scholar
• Lima M A, Bica R B, Araujo A Q. Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis. J Neurol Neurosurg Psychiatry 2005; 76: 294–296
   Google Scholar
• Madeleine M M, Wiktor S Z, Goedert J J, Manns A, Levine P H, Biggar R J, Blattner W A. HTLV-I and HTLV-II world-wide distribution: reanalysis of 4,832 immunoblot results. Int J Cancer 1993; 54: 255–260
   Google Scholar
• Maloney E M, Cleghorn F R, Morgan O S, Rodgers-Johnson P, Cranston B, Jack N, Blattner W A, Bartholomew C, Manns A. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 167–170
   PubMedGoogle Scholar
• Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353: 1951–1958
   PubMed Web of Science ®Google Scholar
• Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, Arimura K, Kubota H, Izumo S, Akiba S, Osame M. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J NeuroVirol 2001; 7: 228–234
   PubMed Web of Science ®Google Scholar
• Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham C R, Izumo S, Osame M. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J NeuroVirol 1998; 4: 586–593
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J NeuroVirol 1995; 1: 50–61
   PubMed Web of Science ®Google Scholar
• Nakamura T, Shibayama K, Nagasato K, Matsuo H, Tsujihata M, Nagataki S. The efficacy of interferon-alpha treatment in human T-lymphotropic virus type-I-associated myelopathy. Jpn J Med 1990; 29: 362–367
   Google Scholar
• Olindo S, Cabre P, Lezin A, Merle H, Saint-Vil M, Signate A, Bonnan M, Chalon A, Magnani L, Cesaire R, Smadja D. Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study. Arch Neurol 2006; 63: 1560–1566
   PubMedGoogle Scholar
• Olindo S, Lezin A, Cabre P, Merle H, Saint-Vil M, Edimonana Kaptue M, Signate A, Cesaire R, Smadja D. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression. J Neurol Sci 2005; 237: 53–59
   PubMed Web of Science ®Google Scholar
• Osame M. Review of WHO Kagoshima Meeting and Diagnostic Guidelines for HAM/TSP, 1 ed. Raven Press, New York 1990
   Google Scholar
• Roman G C, Spencer P S, Schoenberg B S, Hugon J, Ludolph A, Rodgers-Johnson P, Osuntokun B O, Shamlaye C F. Tropical spastic paraparesis in the Seychelles Islands: a clinical and case-control neuroepidemiologic study. Neurology 1987; 37: 1323–1328
   Google Scholar
• Shakudo M, Inoue Y, Tsutada T. HTLV-Iassociated myelopathy: acute progression and atypical MR findings. AJNR Am J Neuroradiol 1999; 20: 1417–1421
   Google Scholar
• Silva M T, Araujo A. Spinal cord swelling in human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis: magnetic resonance indication for early anti-inflammatory treatment?. Arch Neurol 2004; 61: 1134–1135
   Google Scholar
• Tateno M, Kondo N, Itoh T, Chubachi T, Togashi T, Yoshiki T. Rat lymphoid cell lines with human T cell leukemia virus production. I. Biological and serological characterization. J Exp Med 1984; 159: 1105–1116
   PubMedGoogle Scholar
• Taylor G P, Tosswill J H, Matutes E, Daenke S, Hall S, Bain B J, Davis R, Thomas D, Rossor M, Bangham C R, Weber J N. Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr 1999; 22: 92–100
   PubMed Web of Science ®Google Scholar
• Watanabe M, Yamashita T, Hara A, Murakami T, Ando Y, Uyama E, Mita S, Uchino M. High signal in the spinal cord on T2–weighted images in rapidly progressive tropical spastic paraparesis. Neuroradiology 2001; 43: 231–233
   Google Scholar